Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations

Submitted by Frida Mäkelä on Tue, 12/31/2024 - 14:50
  • Read more about Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations

Association between gynecologic cancer and Alzheimer’s disease: a bidirectional mendelian randomization study

Submitted by Frida Mäkelä on Tue, 12/31/2024 - 14:45
  • Read more about Association between gynecologic cancer and Alzheimer’s disease: a bidirectional mendelian randomization study

Association of maternal gut microbial metabolites with gestational diabetes mellitus: evidence from an original case-control study, meta-analysis, and Mendelian randomization

Submitted by Frida Mäkelä on Tue, 12/31/2024 - 14:40
  • Read more about Association of maternal gut microbial metabolites with gestational diabetes mellitus: evidence from an original case-control study, meta-analysis, and Mendelian randomization

Causal relationship between immune cells and epilepsy mediated by metabolites analyzed through Mendelian randomization

Submitted by Frida Mäkelä on Tue, 12/31/2024 - 14:37
  • Read more about Causal relationship between immune cells and epilepsy mediated by metabolites analyzed through Mendelian randomization

Association between various cathepsins and uterine leiomyoma: A Mendelian randomization analysis

Submitted by Frida Mäkelä on Tue, 12/31/2024 - 14:33
  • Read more about Association between various cathepsins and uterine leiomyoma: A Mendelian randomization analysis

Comprehensive analysis of molecular, physiological, and functional biomarkers of aging with neurological diseases using Mendelian randomization

Submitted by Frida Mäkelä on Tue, 12/31/2024 - 14:28
  • Read more about Comprehensive analysis of molecular, physiological, and functional biomarkers of aging with neurological diseases using Mendelian randomization

Exploring the therapeutic potential of interleukin-6 receptor blockade in cardiovascular disease treatment through Mendelian randomization

Submitted by Frida Mäkelä on Tue, 12/31/2024 - 14:24
  • Read more about Exploring the therapeutic potential of interleukin-6 receptor blockade in cardiovascular disease treatment through Mendelian randomization

A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank

Submitted by Frida Mäkelä on Tue, 12/31/2024 - 14:19
  • Read more about A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank

Mendelian randomization analysis reveals causal effects of blood lipidome on gestational diabetes mellitus

Submitted by Frida Mäkelä on Tue, 12/31/2024 - 14:15
  • Read more about Mendelian randomization analysis reveals causal effects of blood lipidome on gestational diabetes mellitus

An observational and genetic investigation into the association between psoriasis and risk of malignancy

Submitted by Frida Mäkelä on Tue, 12/31/2024 - 14:11
  • Read more about An observational and genetic investigation into the association between psoriasis and risk of malignancy

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 170
  • Page 171
  • Page 172
  • Page 173
  • Current page 174
  • Page 175
  • Page 176
  • Page 177
  • Page 178
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement